ERVW-1 and COVID-19: Because this protease proteolytically cleaved and activated viral envelope glycoproteins during the infection.TMPRSS2polymorphisms were associated with an increased risk of severe COVID-19.3There is no published epigenetic study that shows the interactionTMPRSSgene and COVID-19.